Advertisement
Screener

SUPERNUS PHARMACEUTICALS, INC. (SUPN) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

2.5 / 5 stars · 60/120 Roast Me

SUPERNUS PHARMACEUTICALS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $117.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-03

  • SUPERNUS PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $117.00K.
  • SUPERNUS PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$211.00K, a 803.33% decline year-over-year.
  • SUPERNUS PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $27.00K.
  • SUPERNUS PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $129.00K, a 71.33% decline year-over-year.
  • SUPERNUS PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $145.00K, a 64.11% decline from fiscal 2024.
  • SUPERNUS PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $404.00K, a 84.56% decline from fiscal 2023.
  • SUPERNUS PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $2.62M.
  • SUPERNUS PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$4.75M.
Period endOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filedOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month
2026-06-30$117.00K
10-Q · filed 2026-08-03
-$94.00K
10-Q · filed 2026-08-03
-$67.00K
derived: sum of 3 quarters · filed 2026-08-03
$62.00K
derived: sum of 4 quarters · filed 2026-08-03
2026-03-31-$211.00K
10-Q · filed 2026-05-05
-$184.00K
derived: sum of 2 quarters · filed 2026-05-05
-$55.00K
derived: sum of 3 quarters · filed 2026-05-05
-$96.00K
derived: sum of 4 quarters · filed 2026-08-03
2025-12-31$27.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$156.00K
derived: sum of 2 quarters · filed 2026-03-02
$115.00K
derived: sum of 3 quarters · filed 2026-08-03
$145.00K
10-K · filed 2026-03-02
2025-09-30$129.00K
10-Q · filed 2025-11-06
$88.00K
derived: sum of 2 quarters · filed 2026-08-03
$118.00K
10-Q · filed 2025-11-06
-$149.00K
derived: sum of 4 quarters · filed 2026-08-03
2025-06-30-$41.00K
10-Q · filed 2026-08-03
-$11.00K
10-Q · filed 2026-08-03
-$278.00K
derived: sum of 3 quarters · filed 2026-08-03
$172.00K
derived: sum of 4 quarters · filed 2026-08-03
2025-03-31$30.00K
10-Q · filed 2026-05-05
-$237.00K
derived: sum of 2 quarters · filed 2026-05-05
$213.00K
derived: sum of 3 quarters · filed 2026-05-05
$375.00K
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$267.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$183.00K
derived: sum of 2 quarters · filed 2026-03-02
$345.00K
derived: sum of 3 quarters · filed 2026-03-02
$404.00K
10-K · filed 2026-03-02
2024-09-30$450.00K
10-Q · filed 2025-11-06
$612.00K
derived: sum of 2 quarters · filed 2025-11-06
$671.00K
10-Q · filed 2025-11-06
$1.28M
derived: sum of 4 quarters · filed 2026-03-02
2024-06-30$162.00K
10-Q · filed 2025-08-05
$221.00K
10-Q · filed 2025-08-05
$834.00K
derived: sum of 3 quarters · filed 2026-03-02
$1.40M
derived: sum of 4 quarters · filed 2026-03-02
2024-03-31$59.00K
10-Q · filed 2025-05-06
$672.00K
derived: sum of 2 quarters · filed 2026-03-02
$1.24M
derived: sum of 3 quarters · filed 2026-03-02
$1.79M
derived: sum of 4 quarters · filed 2026-03-02
2023-12-31$613.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$1.18M
derived: sum of 2 quarters · filed 2026-03-02
$1.74M
derived: sum of 3 quarters · filed 2026-03-02
$2.62M
10-K · filed 2026-03-02
2023-09-30$569.00K
10-Q · filed 2024-11-04
$1.12M
derived: sum of 2 quarters · filed 2024-11-04
$2.00M
10-Q · filed 2024-11-04
$2.84M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$554.00K
10-Q · filed 2024-08-06
$1.44M
10-Q · filed 2024-08-06
$2.27M
derived: sum of 3 quarters · filed 2025-02-25
$445.00K
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$881.00K
10-Q · filed 2024-05-08
$1.72M
derived: sum of 2 quarters · filed 2025-02-25
-$109.00K
derived: sum of 3 quarters · filed 2025-02-25
-$1.56M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$836.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$990.00K
derived: sum of 2 quarters · filed 2025-02-25
-$2.44M
derived: sum of 3 quarters · filed 2025-02-25
-$4.75M
10-K · filed 2025-02-25
2022-09-30-$1.83M
10-Q · filed 2023-11-08
-$3.27M
derived: sum of 2 quarters · filed 2023-11-08
-$5.58M
10-Q · filed 2023-11-08
-$8.26M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30-$1.45M
10-Q · filed 2023-08-08
-$3.76M
10-Q · filed 2023-08-08
-$6.43M
derived: sum of 3 quarters · filed 2023-08-08
-$7.65M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$2.31M
10-Q · filed 2023-05-09
-$4.98M
derived: sum of 2 quarters · filed 2023-05-09
-$6.21M
derived: sum of 3 quarters · filed 2023-05-09
-$7.02M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31-$2.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
-$3.89M
derived: sum of 2 quarters · filed 2023-03-09
-$4.71M
derived: sum of 3 quarters · filed 2023-03-09
-$7.44M
10-K · filed 2023-03-09
2021-09-30-$1.22M
10-Q · filed 2022-11-09
-$2.04M
derived: sum of 2 quarters · filed 2022-11-09
-$4.77M
10-Q · filed 2022-11-09
-$5.49M
derived: sum of 4 quarters · filed 2023-03-09
2021-06-30-$816.00K
10-Q · filed 2022-08-08
-$3.54M
10-Q · filed 2022-08-08
-$4.27M
derived: sum of 3 quarters · filed 2023-03-09
-$5.93M
derived: sum of 4 quarters · filed 2023-03-09
2021-03-31-$2.73M
10-Q · filed 2022-05-12
-$3.45M
derived: sum of 2 quarters · filed 2023-03-09
-$5.11M
derived: sum of 3 quarters · filed 2023-03-09
$6.42M
derived: sum of 4 quarters · filed 2023-03-09
2020-12-31-$725.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
-$2.38M
derived: sum of 2 quarters · filed 2023-03-09
$9.14M
derived: sum of 3 quarters · filed 2023-03-09
$1.56M
10-K · filed 2023-03-09
2020-09-30-$1.66M
10-Q · filed 2021-11-05
$9.87M
derived: sum of 2 quarters · filed 2021-11-05
$2.28M
10-Q · filed 2021-11-05
$2.44M
derived: sum of 4 quarters · filed 2022-04-13
2020-06-30$11.53M
10-Q · filed 2021-08-06
$3.94M
10-Q · filed 2021-08-06
$4.10M
derived: sum of 3 quarters · filed 2022-04-13
$5.43M
derived: sum of 4 quarters · filed 2022-04-13
2020-03-31-$7.58M
10-Q · filed 2021-05-07
-$7.43M
derived: sum of 2 quarters · filed 2022-04-13
-$6.09M
derived: sum of 3 quarters · filed 2022-04-13
-$1.59M
derived: sum of 4 quarters · filed 2022-04-13
2019-12-31$156.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13
$1.49M
derived: sum of 2 quarters · filed 2022-04-13
$5.99M
derived: sum of 3 quarters · filed 2022-04-13
$10.57M
10-K · filed 2022-04-13
2019-09-30$1.34M
10-Q · filed 2020-11-06
$5.83M
derived: sum of 2 quarters · filed 2020-11-06
$10.42M
10-Q · filed 2020-11-06
$11.37M
derived: sum of 4 quarters · filed 2021-03-08
2019-06-30$4.50M
10-Q · filed 2020-08-17
$9.08M
10-Q · filed 2020-08-17
$10.04M
derived: sum of 3 quarters · filed 2021-03-08
$10.04M
derived: sum of 4 quarters · filed 2021-03-08
2019-03-31$4.58M
10-Q · filed 2020-05-15
$5.54M
derived: sum of 2 quarters · filed 2021-03-08
$5.55M
derived: sum of 3 quarters · filed 2021-03-08
$3.72M
derived: sum of 4 quarters · filed 2021-03-08
2018-12-31$953.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08
$961.00K
derived: sum of 2 quarters · filed 2021-03-08
-$867.00K
derived: sum of 3 quarters · filed 2021-03-08
-$2.41M
10-K · filed 2021-03-08
2018-09-30$8.00K
10-Q · filed 2019-11-08
-$1.82M
derived: sum of 2 quarters · filed 2019-11-08
-$3.36M
10-Q · filed 2019-11-08
-$4.36M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30-$1.83M
10-Q · filed 2019-08-09
-$3.37M
10-Q · filed 2019-08-09
-$4.37M
derived: sum of 3 quarters · filed 2020-02-28
-$4.33M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31-$1.54M
10-Q · filed 2019-05-10
-$2.54M
derived: sum of 2 quarters · filed 2020-02-28
-$2.51M
derived: sum of 3 quarters · filed 2020-02-28
-$2.32M
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31-$999.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
-$963.00K
derived: sum of 2 quarters · filed 2020-02-28
-$779.00K
derived: sum of 3 quarters · filed 2020-02-28
-$613.00K
10-K · filed 2020-02-28
2017-09-30$36.00K
10-Q · filed 2018-11-09
$220.00K
derived: sum of 2 quarters · filed 2018-11-09
$386.00K
10-Q · filed 2018-11-09
$125.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$184.00K
10-Q · filed 2018-08-09
$350.00K
10-Q · filed 2018-08-09
$89.00K
derived: sum of 3 quarters · filed 2019-03-01
-$333.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$166.00K
10-Q · filed 2018-05-10
-$95.00K
derived: sum of 2 quarters · filed 2019-03-01
-$517.00K
derived: sum of 3 quarters · filed 2019-03-01
-$136.00K
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$261.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$683.00K
derived: sum of 2 quarters · filed 2019-03-01
-$302.00K
derived: sum of 3 quarters · filed 2019-03-01
$354.00K
10-K · filed 2019-03-01
2016-09-30-$422.00K
10-Q · filed 2017-11-09
-$41.00K
derived: sum of 2 quarters · filed 2017-11-09
$615.00K
10-Q · filed 2017-11-09
$234.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30$381.00K
10-Q · filed 2017-08-03
$1.04M
10-Q · filed 2017-08-03
$656.00K
derived: sum of 3 quarters · filed 2018-03-01
$700.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31$656.00K
10-Q · filed 2017-05-09
$275.00K
derived: sum of 2 quarters · filed 2018-03-01
$319.00K
derived: sum of 3 quarters · filed 2018-03-01
$233.00K
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31-$381.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01
-$337.00K
derived: sum of 2 quarters · filed 2018-03-01
-$423.00K
derived: sum of 3 quarters · filed 2018-03-01
-$334.00K
10-K · filed 2018-03-01
2015-09-30$44.00K
10-Q/A · filed 2017-01-20
-$42.00K
derived: sum of 2 quarters · filed 2017-01-23
$47.00K
10-Q/A · filed 2017-01-20
-$72.00K
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30-$86.00K
10-Q/A · filed 2017-01-23
$3.00K
10-Q/A · filed 2017-01-23
-$116.00K
derived: sum of 3 quarters · filed 2017-03-16
-$152.00K
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$89.00K
10-Q/A · filed 2017-01-20
-$30.00K
derived: sum of 2 quarters · filed 2017-03-16
-$66.00K
derived: sum of 3 quarters · filed 2017-03-16
-$66.00K
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31-$119.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-16
-$155.00K
derived: sum of 2 quarters · filed 2017-03-16
-$155.00K
derived: sum of 3 quarters · filed 2017-03-16
-$154.00K
10-K · filed 2017-03-16
2014-09-30-$36.00K
10-Q/A · filed 2017-01-20
-$36.00K
derived: sum of 2 quarters · filed 2017-01-20
-$35.00K
10-Q/A · filed 2017-01-20
$46.00K
derived: sum of 4 quarters · filed 2017-01-20
2014-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
$1.00K
10-Q · filed 2015-08-07
$82.00K
derived: sum of 3 quarters · filed 2017-01-20
$236.00K
derived: sum of 4 quarters · filed 2017-01-20
2014-03-31$1.00K
10-Q · filed 2015-05-06
$82.00K
derived: sum of 2 quarters · filed 2017-01-20
$236.00K
derived: sum of 3 quarters · filed 2017-01-20
$89.00K
derived: sum of 4 quarters · filed 2017-01-20
2013-12-31$81.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-01-20
$235.00K
derived: sum of 2 quarters · filed 2017-01-20
$88.00K
derived: sum of 3 quarters · filed 2017-01-20
$57.00K
10-K/A · filed 2017-01-20
2013-09-30$154.00K
10-Q · filed 2014-11-12
$7.00K
derived: sum of 2 quarters · filed 2014-11-12
-$24.00K
10-Q · filed 2014-11-12
-$54.00K
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30-$147.00K
10-Q · filed 2014-08-12
-$178.00K
10-Q · filed 2014-08-12
-$208.00K
derived: sum of 3 quarters · filed 2015-03-12
-$243.00K
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31-$32.00K
10-Q · filed 2014-05-13
-$61.00K
derived: sum of 2 quarters · filed 2015-03-12
-$96.00K
derived: sum of 3 quarters · filed 2015-03-12
-$131.00K
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31-$29.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
-$64.00K
derived: sum of 2 quarters · filed 2015-03-12
-$99.00K
derived: sum of 3 quarters · filed 2015-03-12
-$58.00K
10-K · filed 2015-03-12
2012-09-30-$35.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
-$70.00K
derived: sum of 2 quarters · filed 2013-11-13
-$29.00K
10-Q · filed 2013-11-13
2012-06-30-$35.00K
10-Q · filed 2013-11-13
-$3.00K
10-Q · filed 2013-08-14
$6.00K
10-Q · filed 2013-08-14
2012-03-31$8.00K
10-Q · filed 2013-05-15
2011-12-31$1.00K
10-K · filed 2014-03-21
2010-12-31-$2.00K
10-K · filed 2013-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38